These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic. Cighetti R; Ciaramelli C; Sestito SE; Zanoni I; Kubik Ł; Ardá-Freire A; Calabrese V; Granucci F; Jerala R; Martín-Santamaría S; Jiménez-Barbero J; Peri F Chembiochem; 2014 Jan; 15(2):250-8. PubMed ID: 24339336 [TBL] [Abstract][Full Text] [Related]
5. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics. Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A Front Immunol; 2021; 12():631797. PubMed ID: 33815382 [TBL] [Abstract][Full Text] [Related]
6. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold. Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365 [TBL] [Abstract][Full Text] [Related]
7. Development of αGlcN(1↔1)αMan-based lipid A mimetics as a novel class of potent Toll-like receptor 4 agonists. Adanitsch F; Ittig S; Stöckl J; Oblak A; Haegman M; Jerala R; Beyaert R; Kosma P; Zamyatina A J Med Chem; 2014 Oct; 57(19):8056-71. PubMed ID: 25252784 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of a dimeric monosaccharide lipid A mimic and its synergistic effect on the immunostimulatory activity of lipopolysaccharide. Lewicky JD; Ulanova M; Jiang ZH Carbohydr Res; 2011 Sep; 346(13):1705-13. PubMed ID: 21689810 [TBL] [Abstract][Full Text] [Related]
10. Structure-Based Design and Synthesis of Lipid A Derivatives to Modulate Cytokine Responses. Verpalen ECJM; Brouwer AJ; Wolfert MA; Boons GJ Chemistry; 2024 Jun; 30(32):e202400429. PubMed ID: 38587187 [TBL] [Abstract][Full Text] [Related]
11. Evidence of a specific interaction between new synthetic antisepsis agents and CD14. Piazza M; Yu L; Teghanemt A; Gioannini T; Weiss J; Peri F Biochemistry; 2009 Dec; 48(51):12337-44. PubMed ID: 19928913 [TBL] [Abstract][Full Text] [Related]
13. Structural regions of MD-2 that determine the agonist-antagonist activity of lipid IVa. Muroi M; Tanamoto K J Biol Chem; 2006 Mar; 281(9):5484-91. PubMed ID: 16407172 [TBL] [Abstract][Full Text] [Related]
14. Involvement of microbial components and toll-like receptors 2 and 4 in cytokine responses to air pollution particles. Becker S; Fenton MJ; Soukup JM Am J Respir Cell Mol Biol; 2002 Nov; 27(5):611-8. PubMed ID: 12397021 [TBL] [Abstract][Full Text] [Related]
15. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide. Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800 [TBL] [Abstract][Full Text] [Related]
16. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4. Muroi M; Tanamoto K Infect Immun; 2002 Nov; 70(11):6043-7. PubMed ID: 12379680 [TBL] [Abstract][Full Text] [Related]
17. Human MD-2 discrimination of meningococcal lipid A structures and activation of TLR4. Zimmer SM; Zughaier SM; Tzeng YL; Stephens DS Glycobiology; 2007 Aug; 17(8):847-56. PubMed ID: 17545685 [TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterization and biological activity of synthetic TLR4 agonist formulations. Anderson RC; Fox CB; Dutill TS; Shaverdian N; Evers TL; Poshusta GR; Chesko J; Coler RN; Friede M; Reed SG; Vedvick TS Colloids Surf B Biointerfaces; 2010 Jan; 75(1):123-32. PubMed ID: 19748238 [TBL] [Abstract][Full Text] [Related]
19. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2. Ohto U; Fukase K; Miyake K; Shimizu T Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668 [TBL] [Abstract][Full Text] [Related]